Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Respirar (Ciudad Autón. B. Aires) ; 16(2): 113-126, Junio 2024.
Artigo em Espanhol | LILACS, UNISALUD, BINACIS | ID: biblio-1556081

RESUMO

Introducción: En diciembre de 2019, se detectó un brote de enfermedad por un nuevo coronavirus que evolucionó en pandemia con severa morbilidad respiratoria y mortali- dad. Los sistemas sanitarios debieron enfrentar una cantidad inesperada de pacientes con insuficiencia respiratoria. En Argentina, las medidas de cuarentena y control sani - tario retrasaron el primer pico de la pandemia y ofrecieron tiempo para preparar el sis- tema de salud con infraestructura, personal y protocolos basados en la mejor evidencia disponible en el momento. En una institución de tercer nivel de Neuquén, Argentina, se desarrolló un protocolo de atención para enfrentar la pandemia adaptado con la evo- lución de la mejor evidencia y evaluaciones periódicas de la mortalidad hospitalaria. Métodos: Estudio de cohorte observacional para evaluar la evolución de pacientes con COVID-19 con los protocolos asistenciales por la mortalidad hospitalaria global y al día 28 en la Clínica Pasteur de Neuquén en 2020. Resultados: Este informe describe los 501 pacientes diagnosticados hasta el 31 de di- ciembre de 2020. La mortalidad general fue del 16,6% (83/501) y del 12,2% (61/501) al día 28 de admisión. En los 139 (27,7%) pacientes con ventilación mecánica, la mortali- dad general y a los 28 días fue de 37,4% (52/139) y 28,1% (38/139) fallecieron, respec- tivamente. Los factores de riesgo identificados fueron edad, comorbilidades y altos re- querimientos de oxígeno al ingreso. Conclusión: La mortalidad observada en los pacientes hospitalizados en nuestra insti- tución en la primera ola de la pandemia COVID-19 fue similar a los informes internacio- nales y menor que la publicada en Argentina para el mismo período.


Introduction: In December 2019, an outbreak of disease due to a new coronavirus was detected that evolved into a pandemic with severe respiratory morbidity and mortality. Health systems had to face an unexpected number of patients with respiratory failure. In Argentina, quarantine and health control measures delayed the first peak of the pan - demic and offered time to prepare the health system with infrastructure, personnel and protocols based on the best evidence available at the time. In a third level institution of Neuquén, Argentina, a care protocol was developed to confront the pandemic adapted by evolving best evidence and periodic evaluations of hospital mortality. Methods: Observational cohort study to evaluate the evolution of patients hospitalized for COVID-19 with care protocols in terms of overall hospital mortality and at day 28 at the Pasteur Clinic in Neuquén in 2020. Results: This report describes the 501 patients diagnosed until December 31, 2020. Mortality was 16.6% (83/501) and 12.2% (61/501) on day 28 of admission. Among the 139 (27.7%) patients with mechanical ventilation, overall mortality and at 28 days it was 37.4% (52/139) and 28.1% (38/139), respectively. The risk factors identified were age, comorbidities and high oxygen requirements on admission. Conclusion: The mortality observed in patients hospitalized in our institution during the first wave of COVID-19 pandemic was similar to international reports and lower than other publications in Argentina for the same period.


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Respiração Artificial , SARS-CoV-2 , COVID-19/mortalidade , Oxigenoterapia , Argentina/epidemiologia , Atenção Terciária à Saúde , Comorbidade , Fatores de Risco , Mortalidade Hospitalar , Pandemias/estatística & dados numéricos
2.
Respirar (Ciudad Autón. B. Aires) ; 16(1): 5-15, Marzo 2024.
Artigo em Espanhol | LILACS, UNISALUD, BINACIS | ID: biblio-1538330

RESUMO

Objetivos: Millones de pacientes con COVID-19 fueron internados en terapia intensiva en el mundo, la mitad desarrollaron síndrome de dificultad respiratoria aguda (SDRA) y recibieron ventilación mecánica invasiva (VMI), con una mortalidad del 50%. Analiza-mos cómo edad, comorbilidades y complicaciones, en pacientes con COVID-19 y SDRA que recibieron VMI, se asociaron con el riesgo de morir durante su hospitalización.Métodos: Estudio de cohorte observacional, retrospectivo y multicéntrico realizado en 5 hospitales (tres privados y dos públicos universitarios) de Argentina y Chile, durante el segundo semestre de 2020.Se incluyeron pacientes >18 años con infección por SARS-CoV-2 confirmada RT-PCR, que desarrollaron SDRA y fueron asistidos con VMI durante >48 horas, durante el se-gundo semestre de 2020. Se analizaron los antecedentes, las comorbilidades más fre-cuentes (obesidad, diabetes e hipertensión), y las complicaciones shock, insuficiencia renal aguda (IRA) y neumonía asociada a la ventilación mecánica (NAV), por un lado, y las alteraciones de parámetros clínicos y de laboratorio registrados.Resultados: El 69% era varón. La incidencia de comorbilidades difirió para los diferentes grupos de edad. La mortalidad aumentó significativamente con la edad (p<0,00001). Las comorbilidades, hipertensión y diabetes, y las complicaciones de IRA y shock se asociaron significativamente con la mortalidad. En el análisis multivariado, sólo la edad mayor de 60 años, la IRA y el shock permanecieron asociados con la mortalidad. Conclusiones: El SDRA en COVID-19 es más común entre los mayores. Solo la edad >60 años, el shock y la IRA se asociaron a la mortalidad en el análisis multivariado.


Objectives: Millions of patients with COVID-19 were admitted to intensive care world-wide, half developed acute respiratory distress syndrome (ARDS) and received invasive mechanical ventilation (IMV), with a mortality of 50%. We analyzed how age, comor-bidities and complications in patients with COVID-19 and ARDS who received IMV were associated with the risk of dying during their hospitalization.Methods: Observational, retrospective and multicenter cohort study carried out in 5 hospitals (three private and two public university hospitals) in Argentina and Chile, during the second half of 2020.Patients >18 years of age with SARS-CoV-2 infection confirmed by RT-PCR, who devel-oped ARDS and were assisted with IMV for >48 hours, during the second half of 2020, were included. History, the most frequent comorbidities (obesity, diabetes and hyper-tension) and the complications of shock, acute renal failure (AKI) and pneumonia as-sociated with mechanical ventilation (VAP), on the one hand, and the alterations of re-corded clinical and laboratory parameters, were analyzed.Results: 69% were men. The incidence of comorbidities differed for different age groups. Mortality increased significantly with age (p<0.00001). Comorbidities, hyper-tension and diabetes, and complications of ARF and shock were significantly associat-ed with mortality. In the multivariate analysis, only age over 60 years, ARF and shock remained associated with mortality.Conclusions: ARDS in COVID-19 is more common among the elderly. Only age >60 years, shock and ARF were associated with mortality in the multivariate analysis


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Pneumonia/complicações , Respiração Artificial/métodos , Síndrome do Desconforto Respiratório do Recém-Nascido/complicações , Choque/complicações , Comorbidade , Insuficiência Renal/complicações , SARS-CoV-2 , COVID-19/epidemiologia , Argentina/epidemiologia , Chile/epidemiologia , Fatores de Risco , Mortalidade , Estudo Multicêntrico
3.
J Bras Pneumol ; 48(5): e20220018, 2022.
Artigo em Inglês, Português | MEDLINE | ID: mdl-36350951

RESUMO

OBJECTIVE: To evaluate COVID-19 knowledge, attitudes, and practices among health care workers (HCWs) practicing in Latin American countries during the first surge of the COVID-19 pandemic. METHODS: This was a multinational cross-sectional survey study, using an online self-administered questionnaire. The final version of the questionnaire comprised 40 questions, organized in five sections: demographic and professional characteristics; COVID-19 knowledge; attitudes toward COVID-19; COVID-19 practices; and institutional resources. RESULTS: The study involved 251 HCWs from 19 Latin American countries who agreed to participate. In our sample, 77% of HCWs participated in some sort of institutional training on COVID-19, and 43% had a low COVID-19 knowledge score. COVID-19 knowledge was associated with the type of health center (public/private), availability of institutional training, and sources of information about COVID-19. Concerns about not providing adequate care were reported by 60% of the participants. The most commonly used ventilatory strategies were protective mechanical ventilation, alveolar recruitment maneuvers, and prone positioning, and the use of drugs to treat COVID-19 was mainly based on institutional protocols. CONCLUSIONS: In this multinational study in Latin America, almost half of HCWs had a low COVID-19 knowledge score, and the level of knowledge was associated with the type of institution, participation in institutional training, and information sources. HCWs considered that COVID-19 was very relevant, and more than half were concerned about not providing adequate care to patients.


Assuntos
COVID-19 , Humanos , COVID-19/epidemiologia , COVID-19/terapia , Pandemias , SARS-CoV-2 , América Latina/epidemiologia , Conhecimentos, Atitudes e Prática em Saúde , Estudos Transversais , Pessoal de Saúde
4.
J. bras. pneumol ; 48(5): e20220018, 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1405427

RESUMO

ABSTRACT Objective: To evaluate COVID-19 knowledge, attitudes, and practices among health care workers (HCWs) practicing in Latin American countries during the first surge of the COVID-19 pandemic. Methods: This was a multinational cross-sectional survey study, using an online self-administered questionnaire. The final version of the questionnaire comprised 40 questions, organized in five sections: demographic and professional characteristics; COVID-19 knowledge; attitudes toward COVID-19; COVID-19 practices; and institutional resources. Results: The study involved 251 HCWs from 19 Latin American countries who agreed to participate. In our sample, 77% of HCWs participated in some sort of institutional training on COVID-19, and 43% had a low COVID-19 knowledge score. COVID-19 knowledge was associated with the type of health center (public/private), availability of institutional training, and sources of information about COVID-19. Concerns about not providing adequate care were reported by 60% of the participants. The most commonly used ventilatory strategies were protective mechanical ventilation, alveolar recruitment maneuvers, and prone positioning, and the use of drugs to treat COVID-19 was mainly based on institutional protocols. Conclusions: In this multinational study in Latin America, almost half of HCWs had a low COVID-19 knowledge score, and the level of knowledge was associated with the type of institution, participation in institutional training, and information sources. HCWs considered that COVID-19 was very relevant, and more than half were concerned about not providing adequate care to patients.


RESUMO Objetivo: Avaliar o conhecimento, atitudes e práticas em relação à COVID-19 entre profissionais de saúde atuantes em países da América Latina durante o primeiro surto da pandemia. Métodos: Estudo multinacional transversal com uso de questionário on-line autoaplicável. A versão final do questionário foi composta por 40 perguntas, organizadas em cinco seções: características demográficas e profissionais; conhecimento sobre COVID-19; atitudes em relação à COVID-19; práticas relacionadas à COVID-19; e recursos institucionais. Resultados: O estudo envolveu 251 profissionais de saúde de 19 países da América Latina que aceitaram participar. Em nossa amostra, 77% dos profissionais de saúde participaram de algum tipo de treinamento institucional sobre COVID-19 e 43% tiveram baixa pontuação de conhecimento sobre COVID-19. O conhecimento sobre COVID-19 apresentou associação com o tipo de instituição de saúde (pública/privada), disponibilidade de treinamento institucional e fontes de informação. Receio de não prestar atendimento adequado foi relatado por 60% dos participantes. As estratégias ventilatórias mais utilizadas foram ventilação mecânica protetora, manobras de recrutamento alveolar e posição prona, e o uso de medicamentos para tratar a COVID-19 foi baseado principalmente em protocolos institucionais. Conclusões: Neste estudo multinacional na América Latina, quase metade da amostra teve baixa pontuação de conhecimento sobre COVID-19 e o nível de conhecimento apresentou associação com o tipo de instituição, participação em treinamento institucional e fontes de informação. Os profissionais de saúde consideravam a COVID-19 muito relevante, e mais da metade tinha receio de não prestar atendimento adequado aos pacientes.

5.
ERJ Open Res ; 7(1)2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33532459

RESUMO

This document constitutes a summary of the clinical practice guidelines (CPGs) prepared at the initiative of the Latin American Thoracic Society (ALAT). Due to new evidence in the treatment of severe asthma, it was agreed to select six clinical questions, and the corresponding recommendations are provided herein. After considering the quality of the evidence, the balance between desirable and undesirable impacts and the feasibility and acceptance of procedures, the following recommendations were established. 1) We do not recommend the use of an inhaled corticosteroid (ICS) plus formoterol as rescue medication in the treatment of severe asthma. 2) We suggest performing many more high-quality randomised studies to evaluate the efficacy and safety of tiotropium in patients with severe asthma. 3) Omalizumab is recommended in patients with severe uncontrolled allergic asthma with serum IgE levels above 30 IU. 4) Anti-interleukin (IL)-5 drugs are recommended in patients with severe uncontrolled eosinophilic asthma (cut-off values above 150 cells·µL-1 for mepolizumab and above 400 cells·µL-1 for reslizumab). 5) Benralizumab is recommended in adult patients with severe uncontrolled eosinophilic asthma (cut-off values above 300 cells·µL-1). 6) Dupilumab is recommended in adult patients with severe uncontrolled allergic and eosinophilic asthma and in adult patients with severe corticosteroid-dependent asthma.

6.
Rev Fac Cien Med Univ Nac Cordoba ; 77(2): 61-67, 2020 04 07.
Artigo em Espanhol | MEDLINE | ID: mdl-32558506

RESUMO

Objective: Evaluate the prevalence of asthma risk in subject of 13-14 years old that were exposed to volcanic ash. One year after the eruption of the Calbuco Volcano and in 2 cities with different degrees of exposure. Methods: Cross-sectional study was developed in subjects of 13-14 years old of two Patagonian cities: San Carlos de Bariloche and Cipolletti. The ISAAC questionnaire and video questionnaire was applied to determine asthma risk. Demographic and perception of exposure variables were assessed. Results: 511 subjects were surveyed in both cities. The prevalence of asthma at risk symptoms was higher in Bariloche 14% compared to Cipolletti 10%, but this difference was not statistically significant (p=0.32). A significant increase in the perception of volcanic ash exposure was reported 14% in Bariloche city vs. 6% in Cipolletti city, p<0.05. Conclusions: After 18 months of volcanic eruption with respiratory ash exposure and the lack of respiratory symptoms difference between two cities with different degree of exposure, this factor may not contribute to have a clinical impact in respiratory health.


Objetivo: Evaluar la prevalencia de riesgo de asma en adolescentes expuestos a ceniza volcánica a un año de la erupción del Volcán Calbuco, en 2 ciudades con diferentes grado de afectación. Métodologia: Estudio de Corte Transversal, en adolescentes de 13-14 años en dos ciudades con diferente grado de exposición a ceniza volcánica: San Carlos de Bariloche y Cipolletti. Se aplicó cuestionario y video-cuestionario ISAAC para determinar riesgo de asma. Las variables demográficas y percepción de exposición, se obtuvieron por cuestionario previo a la aplicación de metodología ISAAC. Resultados: Se encuestaron 511 sujetos en total. Se reportó prevalencia de síntomas de riesgo de asma en Bariloche resultó de 14% comparado con Cipolletti que reportó 10% (p=0.32). Se informó mayor exposición a ceniza volcánica en la ciudad de Bariloche vs. Cipolletti; 14% y 6% respectivamente con p<0.05. Conclusiones: La falta diferencia estadisticamente significativa respecto a la prevalencia de sintomas de riesgo de asma entre ambas poblaciones con diferente nivel de exposición y tras 18 meses de la erupción volcánica mas exposición respiratoria a ceniza volcánica, pareciera no presentar impacto clínico en la salud respiratoria.


Assuntos
Poluentes Atmosféricos/efeitos adversos , Asma/epidemiologia , Asma/etiologia , Erupções Vulcânicas/efeitos adversos , Adolescente , Argentina/epidemiologia , Estudos Transversais , Feminino , Humanos , Masculino , Material Particulado/efeitos adversos , Prevalência , Fatores de Risco
7.
Rev. am. med. respir ; 19(2): 112-118, jun. 2019. graf, map, tab
Artigo em Espanhol | LILACS | ID: biblio-1041687

RESUMO

Antecedentes: Las personas expuestas a cenizas volcánicas presentan incremento de los síntomas respiratorios. La duración de la exposición, las características y concentración de la ceniza son determinantes en el impacto sobre la salud respiratoria. Objetivos: Describir la prevalencia de sibilancias en el último año en la población adulta expuesta a la caída de ceniza volcánica en dos ciudades con diferente nivel de exposición. Secundariamente describir la prevalencia de síntomas oculares y respiratorios en esas poblaciones. Materiales y métodos: Se realizó estudio de corte transversal cinco días después de la erupción del volcán Calbuco, en dos ciudades patagónicas con diferente nivel de exposición (alta y baja exposición). La prevalencia de sibilancias, síntomas respiratorios y oculares, se evaluaron mediante la encuesta telefónica por sistema interactivo de voz. Resultados: La prevalencia de sibilancias fue similar en las ciudades de baja y alta exposición (30.2% vs. 31.0%; p: 0.82). Los síntomas respiratorios y los síntomas oculares fueron 32% y 57% respectivamente (p: NS). Conclusión: Luego de la erupción del volcán Calbuco, una alta proporción de la población expuesta reportó sibilancias, síntomas respiratorios y oculares. No se demostraron diferencias entre las ciudades analizadas. La prevalencia de sibilancias fue mayor en estas ciudades que la reportada a nivel nacional. Síntomas respiratorios, prevalencia de sibilancias en adultos mayor a lo reportado por a nivel nacional.


Assuntos
Doenças Respiratórias , Infecções Respiratórias , Asma , Erupções Vulcânicas
8.
Rev. am. med. respir ; 19(2): 119-124, jun. 2019. graf, map, tab
Artigo em Inglês | LILACS | ID: biblio-1041688

RESUMO

History: People exposed to volcanic ash show increased respiratory symptoms. The duration of exposure, the characteristics and ash concentration are determinants of the impact on respiratory health. Objectives: To describe the prevalence of wheezing over the past year within the adult population exposed to volcanic ash spilling in two cities with different levels of exposure. Secondarily, to describe the prevalence of ocular and respiratory symptoms in those populations. Materials and methods: A cross-sectional study was conducted five days after the eruption of the Calbuco volcano in two Patagonian cities with different levels of exposure (high and low levels of exposure). The prevalence of wheezing and respiratory and ocular symptoms was evaluated by means of telephone surveys conducted through an interactive voice response system. Results: The prevalence of wheezing was similar both in cities with low and with high levels of exposure (30.2% vs. 31.0%; p: 0.82). The respiratory and ocular symptoms were 32% and 57%, respectively (p: NS). Conclusion: After the eruption of the Calbuco volcano, a high proportion of the exposed population showed wheezing and respiratory and ocular symptoms. No differences were shown between the analyzed cities. The prevalence of wheezing in these cities was higher than that reported on the national level. The respiratory symptoms and the prevalence of wheezing in adults were higher than those reported on the national level.


Assuntos
Doenças Respiratórias , Infecções Respiratórias , Asma , Erupções Vulcânicas
9.
J Asthma Allergy ; 11: 283-291, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30555245

RESUMO

PURPOSE: Asthma is a highly prevalent noncommunicable lung disease. The aim of this study was to evaluate the longitudinal association of obesity/adiposity with wheezing and atopy. METHODS: The population of the study was composed of participants from the 1993 Pelotas (Brazil) Birth Cohort. The following outcome variables were measured at 22 years: wheezing in the last 12 months, wheezing with atopy, wheezing without atopy, only atopy, and persistent wheezing at 18 and 22 years. Exposure variables were obesity body mass index, percent fat mass (FM), and fat mass index, which were obtained by precise methods (BOD POD and dual-energy X-ray absorptiometry [DXA]). Crude and adjusted logistic and multinomial logistic regressions were used in the analyses. RESULTS: The prevalence of wheezing (with and without atopy), wheezing without atopy, only atopy, and persistent wheezing were 10.6%, 3.9%, 30.9%, and 4.0%, respectively. To be obese or to belong to the highest tertile of obesity/adiposity at two follow-ups showed a cumulative and positive association with wheezing in the adjusted analysis; for atopy there was no significant association. The odds ratio (OR) for wheezing according to the percentage of total FM measured by DXA in the highest tertile at both follow-ups was 1.58 (95% CI: 1.14-2.20) against an OR of 1.16 (95% CI: 0.92-1.47) for atopy. Persistent wheezing was also associated with adiposity, but without statistical significance. CONCLUSIONS: We found a positive longitudinal association between several measures of adiposity and wheezing at 22 years old. The effect was higher for cumulative adiposity; the results for atopy were not consistent.

10.
Arch Bronconeumol ; 53(9): 510-515, 2017 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28483343

RESUMO

Marijuana is the most widely usedillegal drug in the world, with a prevalence of 2.5%-5%, and the second most commonly smoked substance after tobacco. The components of smoke from combustion of marijuana are similar to those produced by the combustion of tobacco, but they differ in terms of psychoactive components and use. Inhalation of cannabis smoke affects the respiratory tract, so the available evidence must be updated in order to provide pulmonologists with the latest scientific information. In this article, we review the impact of cannabis consumption on the lungs, taking into account that the respiratory route is the most popular route of cannabis consumption.


Assuntos
Pneumopatias/etiologia , Fumar Maconha/efeitos adversos , Uso da Maconha/epidemiologia , Animais , Volume Expiratório Forçado , Neoplasias de Cabeça e Pescoço/etiologia , Política de Saúde , Humanos , Pneumopatias/epidemiologia , Neoplasias Pulmonares/etiologia , Fumar Maconha/epidemiologia , Fumar Maconha/legislação & jurisprudência , Primatas , Doença Pulmonar Obstrutiva Crônica/etiologia , Sistema Respiratório/efeitos dos fármacos , Latência do Sono/efeitos dos fármacos , Fumaça/efeitos adversos , Fumar Tabaco/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA